MEDA

MEDA
Names
Preferred IUPAC name
1-(8-Methoxy-2,3-dihydro-1,4-benzodioxin-6-yl)propan-2-amine
Identifiers
CAS Number
3D model (JSmol)
ChemSpider
ECHA InfoCard 100.032.914
Edit this at Wikidata
KEGG
PubChem CID
UNII
InChI
  • InChI=1S/C12H17NO3/c1-8(13)5-9-6-10(14-2)12-11(7-9)15-3-4-16-12/h6-8H,3-5,13H2,1-2H3 ☒N
    Key: NRVFDGZJTPCULU-UHFFFAOYSA-N checkY
  • InChI=1S/C12H17NO3/c1-8(13)5-9-6-10(14-2)12-11(7-9)15-3-4-16-12/h6-8H,3-5,13H2,1-2H3
    Key: HEYPARQBPGSFKW-UHFFFAOYSA-N
SMILES
  • NC(CC1=CC2=C(OCCO2)C(OC)=C1)C
Properties
Chemical formula
 C12H17NO3
Molar mass 223.272 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)
Infobox references

MEDA (3-methoxy-4,5-ethylenedioxyamphetamine) is a lesser-known psychedelic drug. MEDA was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 200 mg, and the duration unknown.[1] MEDA produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MEDA.

See also

References


This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.